• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NBI
Click for more information
1.08% $1.87

NB GLOBAL CORPORATE INCOME TRUST - Discussion

Currently unlisted. Proposed listing date: WEDNESDAY, 26 SEPTEMBER 2018 11:00 AM ## watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Nb Global Corporate Income Trust

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock NBI Ann: Appendix 1A Thread ASX News 0 75 0 26/09/18
26/09/18 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 75 Likes Created with Sketch. 0
ASX - By Stock NBI Ann: Product Disclosure Statement Thread ASX News 0 82 0 26/09/18
26/09/18 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 82 Likes Created with Sketch. 0
ASX - By Stock NBI Ann: ASX Notice- Admission & Commencement of Official Quotation Thread ASX News 0 137 0 25/09/18
25/09/18 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 137 Likes Created with Sketch. 0
ASX - By Stock NBI IPO - NB Global Corporate Income Trust Thread IPO News 0 1.2K 0 22/08/18
22/08/18 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 1.2K Likes Created with Sketch. 0
refresh Created with Sketch. REFRESH

Top Stories

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

Australian Rare Earths has asserted it's set to launch follow up drilling after aircore results show potential uranium downhole at Overland.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Chimeric clocks $4.17M R&D tax rebate from Canberra Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17M tax rebate from Canberra for R&D activities.
Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees The Australian Competition and Consumer Commission has alleged Webjet (ASX:WJL) misled its customers @ and breached consumer law in the process @ by billing its available airfares as cheap but failing to properly disclose compulsory service and booking fees that then had an impact on final prices...
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.